SPOTLIGHT -
The fungal meningitis outbreak can serve as a reminder of the need for risk management.
Rezafungin for Injection to Treat Candidemia and Invasive Candidiasis Gets FDA Approval
The drug, branded as Rezzayo, is the first FDA-approved invasive candidiasis treatment in over a decade.
Looking to the Future of Independent Pharmacy
Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.
Treatment For Rare Immunodeficiency Disease Gets FDA Approval
The drug Leniolisib, now with the brand name Joenja, treats APDA, a genetic disorder that impairs the immune system. Its annual list price will be $547,500.
Podcast: Pharmacy Financing With First Financial Bank
Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.
Pharmacy’s Role in Managing Medical Misinformation
Are pharmacists obligated to correct medical misinformation they encounter online?
NDA For Extended-Release Jakafi Rejected by FDA
Regulatory officials said additional requirements are needed in order to approve the drug, which is under review for treatment of myelofibrosis, polycythemia vera, and graft-versus-host disease.